Found 4370 articles for: ""
Local Blistering Reaction Complicating Subcutaneous Injection of Pegylated Interferon in a Patient with Hepatitis C
February 2003 | Volume 2 | Issue 1 | Case Reports | 63 | Copyright © February 2003
PEG-Intron is a covalent conjugate of recombinant alpha-2b interferon with monomethoxy polyethylene glycol (PEG). Compared to standard interferon-alpha injections, this preparation has a longer half-...
Read MoreUnregulated Alternative Medicine
February 2003 | Volume 2 | Issue 1 | Original Article | 58 | Copyright © February 2003
Unconventional (i.e. alternative, traditional, or complementary) treatments are used by many individuals for a variety of symptoms and disorders. Reports on fraudulent products used for unconventiona...
Read MoreCiclopirox Olamine: Head to Foot
February 2003 | Volume 2 | Issue 1 | Original Article | 50 | Copyright © February 2003
Ciclopirox is a hydroxylated pyridone, a unique substance in our tropical treatment armamentarium. It first came to market in Europe and has been in use for a number of years1. Worldwide it...
Read MoreBrittle Nails: Pathogenesis and Treatment
February 2003 | Volume 2 | Issue 1 | Original Article | 48 | Copyright © February 2003
Thalidomide as Elective Treatment in Persitent Erythema Mutliforme ; Report of Two Cases
February 2003 | Volume 2 | Issue 1 | Original Article | 40 | Copyright © February 2003
Recurrent erythema multiforme is a rare disorder, clinically characterized by symmetrically distributed, erythematous, and bullous skin and mucous lesions, mainly precipitated by a preceding herpes s...
Read MoreAn Update on Newer Topical Therapies for Actinic Keratoses; Advances and Applications
February 2003 | Volume 2 | Issue 1 | Original Article | 35 | Copyright © February 2003
The use of topical agents for treatment of most dermatologic disorders is integral to the practice of dermatology. The innate properties and therapeutic mechanisms of the active component(s) of a top...
Read MoreOnychomycosis in Children: an overview
February 2003 | Volume 2 | Issue 1 | Original Article | 31 | Copyright © February 2003
Onychomycosis in children is relatively uncommon, with a prevalence of approximately 0.3% worldwide. The most common etiologic organism is Trichophyton rubrum. The oral antifungal agents terbinafine,...
Read MoreOral Calcitriol: A New Therapeutic Agent In Cutaneous Lichen Scerosis
February 2003 | Volume 2 | Issue 1 | Original Article | 28 | Copyright © February 2003
Background: Lichen sclerosus remains an elusive disease with an uncertain relationship to morphea and scleroderma. The disorder has been difficult to treat, with no consistent and reproducible effica...
Read MoreIvermectin in Dermatology
February 2003 | Volume 2 | Issue 1 | Original Article | 13 | Copyright © February 2003
Ivermectin, a broad-spectrum anti-parasitic agent first used in veterinary medicine, is active against numerous species of helminths and arthropods. For the past few years, world-wide reports on the ...
Read MorePemphigus Foliaceus Presenting As Eruptive Seborrheic Keratosis and Responding to Oral Gold Treatment
December 2002 | Volume 1 | Issue 3 | Case Reports | 333 | Copyright © December 2002
Pemphigus Foliaceus (PF) is an antibody-mediated autoimmune disease. IgG directed against desmoglein-1 induces acantholysis in the superficial epidermis, leading to the classic presentation of cruste...
Read MoreManagement of Obstructive Airway Hemangiomans in the Neonate
December 2002 | Volume 1 | Issue 3 | Case Reports | 331 | Copyright © December 2002
Hemangiomas are benign neoplasms of vascular endothelium. They represent the most common pediatric tumor and are seen in 8-12% of Caucasian children by age 11. Hemangiomas have a female predilection, ...
Read MoreIrbesartan- Associated Persistant Edema of the Eyelids, Face, and Neck
December 2002 | Volume 1 | Issue 3 | Case Reports | 329 | Copyright © December 2002
Irbesartan, an angiotensin II receptor antagonist(AIIRA), is an antihypertensive agent that inhibits the activity of angiotensin II by selectively binding to angiotensin II type 1 (AT1) receptors. The...
Read MoreA Young Boy with Symmetric Hyperkeratotic Plaques: Progressive Symmetric Erythrokeratoderma (PSEK)
December 2002 | Volume 1 | Issue 3 | Case Reports | 326 | Copyright © December 2002
In this report, a case is presented of a child, descendent from parents originating in the Virgin Islands, with symmetric and progressive hyperpigmented, hyperkeratotic plaques consistent with progre...
Read MoreThe Skin Cancer Foundation
December 2002 | Volume 1 | Issue 3 | Original Article | 320 | Copyright © December 2002
The New Antihistamines-Desloratadine and Levocetirizine: A Review
December 2002 | Volume 1 | Issue 3 | Original Article | 311 | Copyright © December 2002
Antihistamines are among the most commonly used medications by allergists and dermatologists worldwide. They are used to treat indications such as rhinitis, urticaria, seasonal allergies, and pruritus...
Read MoreBiologic Therapy for Psorasis- The First Wave: Infliximab, Etanercept, Efalizumab, and Alefacept
December 2002 | Volume 1 | Issue 3 | Original Article | 303 | Copyright © December 2002
Over the last several years, a new generation of therapies for psoriasis has been in development. These biologic therapies target the activity of T lymphocytes and cytokines responsible for the infla...
Read MoreThe History of Skin Grafts
December 2002 | Volume 1 | Issue 3 | Original Article | 298 | Copyright © December 2002
The History of Flaps
December 2002 | Volume 1 | Issue 3 | Original Article | 293 | Copyright © December 2002
Surgical Complications
December 2002 | Volume 1 | Issue 3 | Original Article | 283 | Copyright © December 2002
Dermatologic surgery is advancing at a very rapid pace. New procedures are being introduced and older techniques are being used for new applications every day, for both therapeutic and cosmetic purpos...
Read MoreThe Use of Tumescent Anesthetic Solution for Fat Transfer Donor and Recipient Sites
December 2002 | Volume 1 | Issue 3 | Original Article | 279 | Copyright © December 2002
The use of tumescent anesthetic solution first described by Jeffrey Klein, M.D. in 1986 for liposuction has made fat transfer a technique well suited to a dermatologic surgeon's office1. Ov...
Read More